Deepak Fertilisers: FY26 Results — The Story of Two Halves

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1 — At a Glance

Deepak Fertilisers delivered revenue growth of 12% to ₹11,506 Cr in FY26, but the earnings story fractured in half. The first half rode commodity strength and subsidy tailwinds; the second half absorbed a perfect storm: ammonia plant shutdown, fertiliser input-cost shocks, inadequate subsidy pass-through, and global supply disruptions in IPA and mining chemicals. Net profit fell 22% to ₹739 Cr despite lower finance costs—a reminder that top-line growth masks underlying margin stress.

The company navigated structural headwinds with two massive capex projects (₹4,650 Cr total) now 95% and 86% complete, commissioning expected Q2 FY27. Management signals improving conditions ahead: tightening global supply, LNG contract first cargo arrived, and strategic mix upgrades. The balance sheet is stretched—net debt at ₹4,824 Cr, 2.86x EBITDA—but consistent with the final stage of a major investment cycle.

The core tension: revenue grew while profitability fell, and the company is about to add significant new capacity into a normalizing market. Does the capex-driven growth in FY27 justify today’s multiple, or is the market pricing for a reset?

2 — Introduction

Deepak Fertilisers operates across three chemistry verticals: mining explosives (Technical Ammonium Nitrate), industrial chemicals (nitric acid, isopropyl alcohol), and crop nutrition (NPK, specialty fertilisers). The company was incorporated in 1979 and is India’s only solid-TAN manufacturer and one of Asia’s largest nitric acid producers.

FY26 marked a year of contradictions. Management’s own language—”a story of two halves”—framed H1 as strong, H2 as materially weaker due to exogenous shocks. Revenue grew 12% YoY; EBITDA contracted 13%. The company received its first LNG cargo from a 15-year Equinor contract, a structural hedge against gas-cost volatility. Simultaneously, it completed an acquisition in explosives (Chardham Chemicals) to pursue vertical integration in mining solutions. The board recommended a 100% dividend (₹10 per share) despite net profit decline.

Two projects dominate the forward outlook: Gopalpur TAN (₹2,675 Cr capex, 376 KTPA capacity) and Dahej nitric acid (₹1,983 Cr capex, adding 300 KTPA WNA and 150 KTPA CNA). Both are 86–95% complete and expected to commission in Q2 FY27, bringing total capex deployed to ₹1,569 Cr in FY26 alone.

3 — Business Model: WTF Do They Even Do?

Deepak Fertilisers is a chemical conglomerate selling three product classes to wildly different customers. The business model works because the company has built scale, location advantage, and application-specific product depth in each vertical.

Mining Chemicals / TAN (26% of FY26 revenue, ₹2,604 Cr): The company sells Technical Ammonium Nitrate—a precursor to explosives—to mining companies, tunnel-boring contractors, and infrastructure projects. It is India’s only solid-TAN manufacturer and the only producer of high-density, low-density, and medical-grade variants. Plants sit on India’s east and west coasts, proximate to mining belts. The company now sells 16% of TAN direct to end-users (B2C), a strategic shift from the traditional B2B model to mining exploder companies. This mix upgrade improves realisations and customer lock-in.

Industrial Chemicals / Nitric Acid and IPA (18% of FY26 revenue, ₹1,842 Cr): The company is the largest nitric acid manufacturer in Asia and a major producer of isopropyl alcohol (IPA, a solvent for pharma, cosmetics, and electronics). It operates a 70 KTPA IPA plant and diluted/concentrated nitric acid plants totalling 885 and 231 KTPA respectively. Geographic advantage is stark: Dahej and Gujarat plants sit in the nitro-aromatic and chemical derivatives belt; Panipat serves northern India; Taloja serves Maharashtra. The company is exploring specialty grades—solar-grade nitric acid, pharmaceutical-grade IPA, and electronic-grade IPA—to move upstream into value-added verticals.

Crop Nutrition (50% of FY26 revenue, ₹6,166 Cr): This is the volume game—NPK, urea, and specialty fertilisers under the brands Smartek and Croptek. The company is not the largest, but it leads in specialty and water-soluble fertilisers (Bentonite Sulphur, for example). It enjoys scale on NPK (800 KTPA capacity) and access to the richest agricultural belts of Maharashtra and Karnataka. The leverage here is subsidy—the Indian government subsidizes fertiliser farmers; swings in subsidy lag cause margin compression even as costs spike. Specialties (33% of segment revenue in FY26) carry better premiums and insulate the business from commodity pricing wars.

The business model is defensible because each vertical has structural moats: TAN (only manufacturer), nitric acid (largest scale in Asia), and specialty fertilisers (brand and application depth). The trade-off is leverage to commodity cycles and government policy.

4 — Financials Overview

Figures are consolidated, in ₹ crore.

The earnings decline is a story of input-cost pass-through failure. Management disclosed that Q4 carried a planned ammonia shutdown impact of ₹70–75 Cr (about 10% of quarterly EBITDA). Adjusting this, underlying FY26 EBITDA would have been ₹1,759 Cr, still a -9% YoY decline. The core driver was margin compression in fertilisers—raw materials (phosphoric acid, sulphur, ammonia) spiked due to Russia-Ukraine disruptions